There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Evaluation of the effects of an experimental long-acting non-ergot dopamine agonist,
CV 205-502, on serum prolactin, tumor size, gonadal function, visual abnormalities,
and tolerability in patients with macroprolactinomas.